Q1 Earnings Snapshot 2026 – Winners, Surprises & Misses Revealed!

⚠️ Weak quarter — sales grew marginally, but sharp EBITDA and profit declines indicate significant margin pressure.

Verdict

Sales grew strongly YoY, but profitability declined sharply both YoY and QoQ. Mixed quarter; near-term performance remains weak.

Strong YoY growth, but sharp QoQ decline across sales and profitability. At 111.3x P/E, valuation remains demanding.

Sales remain weak YoY, but strong QoQ growth and narrowing losses are positive. Profitability remains under pressure.

Strong YoY operating growth, but sharp QoQ decline in profit and EPS is a key concern.

Weak quarter — revenue was broadly flat YoY but declined sharply QoQ, while profit and EPS saw significant YoY and QoQ pressure. At 39.1x P/E, valuation remains demanding despite the weak earnings.

🟢 Strong YoY performance with healthy sales and EBITDA growth, though profit and EPS softened slightly QoQ. At 115.7x P/E, valuation remains demanding and requires strong future growth to justify the premium.

🟢 Strong quarter — sales and EBIDT growth remained robust, with healthy QoQ improvement in profit and EPS.

🟢 Strong quarter — Profit and EBITDA growth remained robust despite a slight QoQ sales decline. However, the valuation at 38.3x P/E remains premium.

Strong quarter — profit growth was significantly ahead of sales, though QoQ revenue declined. Valuation at 45.9 PE remains demanding.

🟢 Strong YoY sales growth and EPS improvement, but sharp QoQ decline in profitability and EBITDA is a near-term concern.

🟢 Strong YoY growth, but QoQ profit and EBITDA declined.

Weak quarter — sales declined, while profitability fell sharply YoY and QoQ. Valuation at 11.1x P/E looks reasonable, but earnings momentum remains weak.

🟢 Positive YoY growth, but QoQ profitability declined.

Strong QoQ recovery with sharp EBIDT growth, but YoY profit and EPS remain lower. At 9.5 PE, valuation looks reasonable.

🟢 Strong quarter — healthy ~20% YoY growth with sequential improvement across key metrics. Valuation remains premium at 48.5 PE.

🟢 Strong YoY growth, but QoQ performance weakened sharply. At 33.2x P/E, valuation leaves limited room for disappointment.

🟠 Mixed quarter — Sales improved, but YoY profitability declined sharply; QoQ recovery is strong. At 25.2× P/E, valuation remains reasonable but earnings recovery needs monitoring.

Verdict

Revenue growth remains strong, but the sharp QoQ and YoY decline in EBITDA, net profit and EPS is a concern. With a P/E of 297.2×, the valuation remains very expensive and leaves limited room for earnings disappointment.

🟢 Strong YoY growth, but weak QoQ performance. At 123.7x P/E, valuation remains demanding.

🟢 Strong quarter — profit growth of 58% YoY and 24.3% QoQ, with EBITDA also showing strong momentum.

🟢 Strong quarter — profit growth significantly outpaced sales, with Net Profit rising 83.7% YoY and 31.2% QoQ. EBIDT also showed strong momentum, increasing 40.5% YoY and 20.0% QoQ.

Verdict: Strong YoY performance with sharp QoQ improvement in sales and EBITDA, but the large QoQ drop in profit needs monitoring.

🟢 Strong quarter — profit and EBITDA growth significantly outpaced sales growth, with sharp QoQ improvement.

Strong YoY growth with sharp profit expansion; QoQ sales softened, but profitability improved significantly. Valuation remains reasonable-to-premium at 28.9x P/E.

🟢 Strong quarter — robust YoY growth with healthy QoQ improvement, but valuation remains very expensive at 256.5 PE.